Document is current

Any future updates will be listed below

Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial

Crossref DOI link: https://doi.org/10.1007/s40122-022-00424-7

Published Online: 2022-08-13

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark